India Blocks Exports of Remdesivir and Its Active Pharmaceutical Ingredients
India now prohibits exports of antiviral medication Remdesivir, used to shorten COVID-19 recovery times, along with the drug's active pharmaceutical ingredients, effective with an April 11 trade notice. The products are under Indian Trade Classification Harmonized System Codes Ex 293499…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
and Ex 300490.